NEW YORK, Jan. 24, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of OSI Systems, Inc. (NASDAQ:OSIS) who purchased shares between August 21, 2013 and December 6, 2017. The action, which was filed in the United States District Court for the Central District of California, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) OSI Systems acquired the Albania concession through bribery or other illicit means; (2) OSI Systems transferred 49% of its project company associated with the Albania concession, S2 Albania SHPK, an entity allegedly worth millions, for consideration of less than $5.00; (3) OSI Systems engaged in other illegal acts, including improper sales and cash payments to government officials; (4) these practices caused OSI Systems to be vulnerable to potential civil and criminal liability; and (5) as a result, defendants’ statements about OSI Systems’ business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
Shareholders have until February 5, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sb/osi-systems-inc?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Explores AI Content Marketplace With Media Publishers
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 



